Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S5 from Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer by Inhibiting c-MYC–mediated Tumorigenesis
  1. Home
  2. Publications
  3. Supplementary Figure S5 from Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer by Inhibiting c-MYC–mediated Tumorigenesis

Supplementary Figure S5 from Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer by Inhibiting c-MYC–mediated Tumorigenesis

Authors:
  • XXXuemei Xie
    Xuemei Xie
  • MMMaroua Manai
    Maroua Manai
  • DRDileep R. Rampa
    Dileep R. Rampa
  • JFJon A. Fuson
    Jon A. Fuson
  • ENElizabeth S. Nakasone
    Elizabeth S. Nakasone
  • TPTroy Pearson
    Troy Pearson
  • BKBharat S. Kuntal
    Bharat S. Kuntal
  • DTDebu Tripathy
    Debu Tripathy
  • Naoto T. Ueno
    Naoto T. Ueno
  • JLJangsoon Lee
    Jangsoon Lee

Open Access
Publisher website
Google Scholar
  • 4 June 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.29234043
Abstract
Supplementary Figure S5. Enzalutamide and KRLS-017 combination treatment did not induce apoptosis in AR+ LAR TNBC cells.
Keywords
  • BREAST CANCER
  • PRECLINICAL MODELS
  • SMALL MOLECULE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.